Accolade Inc. (ACCD): Price and Financial Metrics


Accolade Inc. (ACCD): $8.44

-0.17 (-1.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ACCD to Watchlist
Sign Up

Industry: Internet


Ranked

of

in industry

ACCD POWR Grades

  • Value is the dimension where ACCD ranks best; there it ranks ahead of 61.45% of US stocks.
  • The strongest trend for ACCD is in Momentum, which has been heading down over the past 179 days.
  • ACCD ranks lowest in Quality; there it ranks in the 11th percentile.

ACCD Stock Summary

  • ACCOLADE INC's stock had its IPO on July 2, 2020, making it an older stock than merely 13.2% of US equities in our set.
  • Over the past twelve months, ACCD has reported earnings growth of 175.06%, putting it ahead of 90.84% of US stocks in our set.
  • In terms of volatility of its share price, ACCD is more volatile than 85.89% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to ACCOLADE INC, a group of peers worth examining would be BLND, CDLX, DM, BLFS, and EGLX.
  • Visit ACCD's SEC page to see the company's official filings. To visit the company's web site, go to accolade.com.

ACCD Valuation Summary

  • In comparison to the median Technology stock, ACCD's price/sales ratio is 23.08% lower, now standing at 2.
  • Over the past 29 months, ACCD's price/sales ratio has gone down 8.5.

Below are key valuation metrics over time for ACCD.

Stock Date P/S P/B P/E EV/EBIT
ACCD 2022-11-14 2.0 1.4 -1.7 -1.7
ACCD 2022-11-11 2.0 1.4 -1.7 -1.7
ACCD 2022-11-10 1.9 1.3 -1.7 -1.7
ACCD 2022-11-09 1.7 1.2 -1.5 -1.5
ACCD 2022-11-08 1.9 1.3 -1.6 -1.6
ACCD 2022-11-07 1.9 1.3 -1.6 -1.6

ACCD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ACCD has a Quality Grade of D, ranking ahead of 16.91% of graded US stocks.
  • ACCD's asset turnover comes in at 0.297 -- ranking 433rd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ACCD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-31 0.297 0.433 -2.101
2021-05-31 0.369 0.447 -2.074
2021-02-28 0.512 0.450 2.793
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310

ACCD Price Target

For more insight on analysts targets of ACCD, see our ACCD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.00 Average Broker Recommendation 1.18 (Strong Buy)

ACCD Stock Price Chart Interactive Chart >

Price chart for ACCD

ACCD Price/Volume Stats

Current price $8.44 52-week high $28.04
Prev. close $8.61 52-week low $4.61
Day low $8.34 Volume 166,800
Day high $8.70 Avg. volume 1,147,489
50-day MA $10.68 Dividend yield N/A
200-day MA $11.19 Market Cap 607.17M

Accolade Inc. (ACCD) Company Bio


Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Seattle, WA.


ACCD Latest News Stream


Event/Time News Detail
Loading, please wait...

ACCD Latest Social Stream


Loading social stream, please wait...

View Full ACCD Social Stream

Latest ACCD News From Around the Web

Below are the latest news stories about ACCOLADE INC that investors may wish to consider to help them evaluate ACCD as an investment opportunity.

Accolade Champions Health Equity and Welcomes FOLX Health to Trusted Partner Ecosystem at HLTH 2022

Accolade, Inc. (Nasdaq: ACCD), which provides millions of people and their families with Personalized Healthcare, will address removing barriers to equitable healthcare as a Health Equity Impact Champion sponsor at HLTH 2022. In addition, LGBTQIA+ affirming care company, FOLX Health, joins Accolade's Trusted Partner Ecosystem, availing high-quality, integrated care for this marginalized population to Accolade 's 700+ commercial and government customers to serve their 11 million members.

Yahoo | November 14, 2022

Accolade Inc. (NASDAQ:ACCD) Stock Dropped -64.72% Year-To-Date, What Analysts Expect Next?

In last trading session, Accolade Inc. (NASDAQ:ACCD) saw 0.48 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $9.30 trading at -$0.47 or -4.81% at ring of the bell on the day assigns it a market valuation of $654.44M. That closing price of ACCD’s stock is at … Accolade Inc. (NASDAQ:ACCD) Stock Dropped -64.72% Year-To-Date, What Analysts Expect Next? Read More »

Marketing Sentinel | November 5, 2022

Analysts Offer Insights on Technology Companies: Accolade (ACCD) and IAC/InteractiveCorp. (IAC)

InteractiveCorp. (IAC – Research Report). Accolade (ACCD) Wells Fargo analyst Stan Berenshteyn maintained a Hold rating on Accolade today and set a price target of $10.00. The company's shares closed last Tuesday at $12.27.

Howard Kim on TipRanks | October 12, 2022

Berenberg Bank Remains a Buy on Accolade (ACCD)

Berenberg Bank analyst Dev Weerasuriya reiterated a Buy rating on Accolade (ACCD - Research Report) today and set a price target of $13.00. The company's shares closed yesterday at $11.40.According to TipRanks, Weerasuriya is an analyst with an average return of -6.4% and a 26.92% success rate. Weerasuriya covers the Technology sector, focusing on stocks such as Omnicell, Health Catalyst, and Doximity.In addition to Berenberg Bank, Accolade also received a Buy from Goldman Sachs's Cindy Motz CFA in a report issued on October 7. However, on the same day, SVB Securities maintained a Hold rating on Accolade (NASDAQ: ACCD).

Catie Powers on TipRanks | October 11, 2022

Accolade Inc. (ACCD) Looks Set To Grow At A Great Clip In 2022

Accolade Inc. (NASDAQ:ACCD) has seen 1.19 million shares traded in the last trading session. The company, currently valued at $882.35M, closed the last trade at $11.48 per share which meant it lost -$0.91 on the day or -7.34% during that session. The ACCD stock price is -260.02% off its 52-week high price of $41.33 and … Accolade Inc. (ACCD) Looks Set To Grow At A Great Clip In 2022 Read More »

Marketing Sentinel | October 10, 2022

Read More 'ACCD' Stories Here

ACCD Price Returns

1-mo -23.34%
3-mo -20.75%
6-mo 31.46%
1-year -68.89%
3-year N/A
5-year N/A
YTD -67.98%
2021 -39.40%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7033 seconds.